To combat Meningococcal disease and prevent its spread, the development and utilization of meningococcal vaccines have played a crucial role. Meningococcal Vaccines are designed to stimulate the body's immune system to produce a protective response against Neisseria meningitidis. These vaccines are available in various formulations, targeting different serogroups of the bacterium, including serogroups A, B, C, W, and Y.

One of the earliest successes in meningococcal disease control was the introduction of the meningococcal serogroup C conjugate vaccine. This vaccine has been highly effective in reducing the incidence of serogroup C meningococcal disease in many countries. It consists of a polysaccharide antigen from the bacterium, coupled with a carrier protein that enhances the immune response. The conjugate vaccine induces both humoral and cellular immune responses, leading to long-lasting protection against serogroup C meningococcal disease.

Read More- https://cmiblogdailydose.blogspot.com/2023/05/meningococcal-vaccines-used-to-protect.html